Park Square Places Brian Stephenson, Ph.D., C.F.A., as Chief Financial Officer at Faeth Therapeutics
Park Square Executive Search is pleased to announce the placement of Brian Stephenson, Ph.D., C.F.A., as Chief Financial Officer at Faeth...
Park Square Executive Search is pleased to announce the placement of Brian Stephenson, Ph.D., C.F.A., as Chief Financial Officer at Faeth...
So pleased for my friend Mathai Mammen, founder Greg Verdine, and all of Parabilis Medicines on this remarkable milestone!
Parabilis Medicines said it would sell 33.5 million shares at $20 apiece, for a total of $670 million.
Park Square Executive Search has placed Pete Ligotti as Chief Commercial Officer at Elutia, a pioneer in drug-eluting biomatrix...
Park Square has placed Aarif Khakoo, MD, MBA as Chief Scientific Officer at Generate:Biomedicines.
Generate:Biomedicines (“Generate”) today announced the appointment of Aarif Khakoo, MD, MBA, as chief scientific officer. A...…
Park Square is excited to announce two placements at Rune Labs: Amy Gordon Franzen has been named Chief Executive Officer, and Adam...
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net